MusthInsider

Latest On Arvinas, Inc (ARVN):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-05 11:16 EST	News	Arvinas GAAP EPS of -$1.54, revenue of $32.5M	N/A
2023-03-30 01:06 EST	News	Arvinas: PROTAC Platform Shows Promise In Clinical Trials For Oncology Indications	N/A
2023-02-23 12:01 EST	News	Arvinas GAAP EPS of -$1.56 misses by $0.39, revenue of $38M beats by $2.68M	N/A
2023-01-20 15:29 EST	News	Bayer, Oerth Bio team up to develop sustainable crop protection products	N/A
2023-01-10 01:57 EST	News	Arvinas falls 17% after early-stage data for Pfizer-partnered tumor therapy	N/A
2023-01-04 02:47 EST	News	Apellis, Arvinas lower as Wells Fargo downgrades in 2023 biotech preview	N/A
2022-12-05 05:02 EST	News	Arvinas: Promising Science, Poor Data	N/A
2022-11-22 16:27 EST	News	Pfizer, Arvinas breast cancer therapy hits 38% clinical benefit in Phase 2 trial	N/A
2022-11-09 02:35 EST	News	Arvinas GAAP EPS of -$1.24 misses by $0.12, revenue of $30.3M misses by $4.42M	N/A
2022-09-09 18:28 EST	News	Arvinas initiated Overweight at Barclays on attractive therapeutic platform	N/A
2022-08-25 09:07 EST	News	Arvinas: Pioneer In Protein Degradation Sports Unappealing Risk/Reward Profile	N/A
2022-08-19 12:16 EST	News	Arvinas a buy at Piper Sandler following failure of Sanofi breast cancer treatment	N/A
2022-08-04 23:37 EST	News	Arvinas GAAP EPS of $1.32 beats by $2.38, revenue of $31.3M beats by $7.59M	N/A
2022-05-23 13:56 EST	News	Arvinas: Still Holding, Just Not Buying More	N/A
2022-05-10 02:23 EST	News	Arvinas stock down 17% after Wedbush downgrades to neutral	N/A
2022-05-05 22:17 EST	News	Arvinas GAAP EPS of -$1.20 misses by $0.28, revenue of $24.2M misses by $1.31M	N/A
2022-03-01 03:13 EST	News	Arvinas GAAP EPS of -$1.00 misses by $0.21, revenue of $26.3M beats by $11.22M	N/A
2022-02-10 23:30 EST	News	Arvinas, Kymera started as biotech overweights at Wells Fargo	N/A
2022-02-07 18:10 EST	News	Arvinas: One Of The Most Interesting Science-Heavy Emerging Biopharma	N/A
2022-01-20 00:57 EST	News	Arvinas, Arrowhead win Buy ratings as Goldman Sachs starts coverage on platform biotechs	N/A
2021-12-10 10:39 EST	News	Pfizer, Arvinas' ARV-471 shows encouraging clinical benefit rate in breast cancer patients	N/A
2021-12-08 02:35 EST	News	Arvinas up following Cowen outperform initiation; sees promise for breast cancer therapy	N/A
2021-11-19 07:46 EST	News	Arvinas: 2022 Is Full Of Catalysts For This Protein Degrader Pioneer	N/A
2021-11-04 04:18 EST	News	Arvinas reports Q3 results	N/A
2021-10-21 00:48 EST	News	Radius Health price target raised on Wall Street after trial win for breast cancer drug	N/A
2021-10-08 03:38 EST	News	Arvinas (ARVN) Investor Presentation - Slideshow	N/A
2021-08-09 23:29 EST	News	Arvinas and Insilico Medicine ink R&D collaboration agreement	N/A
2021-08-05 22:24 EST	News	Arvinas EPS misses by $0.17, beats on revenue	N/A
2021-07-31 23:15 EST	News	Arvinas: Tremendous Value Increase With Pfizer Mega-Deal, High Potential	N/A
2021-07-22 19:19 EST	News	Arvinas, Pfizer team up to develop ARV-471 in breast cancer	N/A
2021-07-22 19:18 EST	News	Arvinas price target raised to a Street-high at Truist on Pfizer deal	N/A
2021-07-20 20:02 EST	News	Connecting The Dots: Are Pfizer And Arvinas At Work On A COVID Cure?	N/A
2021-05-04 15:10 EST	News	Arvinas EPS misses by $0.04, beats on revenue	N/A
2021-03-30 21:25 EST	News	Ascendis downgraded at Oppenheimer, Aytu initiated at overweight at Cantor and more in today's analyst action	N/A
2021-03-30 21:24 EST	News	'Data-rich 2H21' could send Arvinas shares 140% higher, Cantor says	N/A
2021-03-19 13:39 EST	News	Arvina (ARVN) Investor Presentation - Slideshow	N/A
2021-03-12 20:41 EST	News	Merck and Pfizer among top picks to lead 2021 biopharma M&A activity: Goldman Sachs	N/A
2021-03-11 11:08 EST	Analyst Rating	The Analyst Target Price has decreased from $103 to $102.5.	Neutral
2021-03-03 15:07 EST	Financials	Company financials have been released.	Neutral
2021-03-02 11:08 EST	Analyst Rating	The Analyst Target Price has decreased from $103.8 to $103.	Neutral
2021-03-02 11:08 EST	Earnings Estimate	An EPS average of -$3.94 is estimated for the 2022 year.	Sell
2021-03-02 11:08 EST	Earnings Estimate	An EPS average of -$0.84 is estimated for the quarter ending on June 30, 2021.	Buy
2021-02-24 11:07 EST	Analyst Rating	The Analyst Target Price has increased from $96.4 to $103.8.	Buy
2021-01-20 07:09 EST	Analyst Rating	The Analyst Target Price has increased from $94.4 to $96.4.	Buy
2021-01-05 11:12 EST	Analyst Rating	The Analyst Target Price has decreased from $96.18 to $94.4.	Neutral
2021-01-03 00:21 EST	News	Arvinas: Leading In Cutting Edge Protein Degrader Development	N/A
2020-12-22 11:08 EST	Analyst Rating	The Analyst Target Price has increased from $92.64 to $96.18.	Buy
2020-12-16 11:09 EST	Analyst Rating	The Analyst Target Price has increased from $80.36 to $92.64.	Buy
2020-12-16 02:19 EST	News	Arvinas continues the upward trend after dual upgrades	N/A
2020-12-16 02:18 EST	News	Arvinas prices $400M stock offering	N/A

About Arvinas, Inc (ARVN):

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates are ARV-110, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was incorporated in 2013 and is based in New Haven, Connecticut.

See Advanced Chart

General

Name Arvinas, Inc
Symbol ARVN
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 179
Fiscal Year EndDecember
IPO Date2018-09-27
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryPharmaceuticals
Gic SubIndustryPharmaceuticals
Web URLhttp://www.arvinas.com

Valuation

Price/Sales (Trailing 12 Mt.) 131.11
Price/Book (Most Recent Quarter) 5.5
Enterprise Value Revenue 130.68

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$3.37
Next Year EPS Estimate -$3.96
Next Quarter EPS Estimate -$0.73
Operating Margin -573%
Return on Assets -15%
Return on Equity -27%
Revenue 21.8 million
Earnings Per Share -$7.16
Revenue Per Share $0.55
Gross Profit 21.8 million
Quarterly Earnings Growth -54.7%

Highlights

Market Capitalization 3.26 billion
EBITDA -64270736
PE Ratio -5.55
Analyst Target Price $102.5
Book Value Per Share $13.26

Share Statistics

Shares Outstanding 48.46 million
Shares Float 41.19 million
% Held by Insiders 1204%
% Held by Institutions 76.78%
Shares Short 1.78 million
Shares Short Prior Month 1.64 million
Short Ratio 3.96
Short % of Float 4%
Short % of Shares Outstanding 4%

Technicals

Beta 2.18
52 Week High $92.77
52 Week Low $19.68
50 Day Moving Average 76.84
200 Day Moving Average 49.59

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

Arvinas, Inc (ARVN) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

Arvinas, Inc (ARVN) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-03-01	$N/A	-$0.99	-$0.73	-35.82%
2020-09-30	2020-11-05	$7.6 million	-$0.79	-$0.66	-19.75%
2020-06-30	2020-08-04	$N/A	-$0.65	-$0.59	-10.96%
2020-03-31	2020-04-28	$6.24 million	-$0.56	-$0.59	5.08%
2019-12-31	2020-03-16	$4.89 million	-$0.56	-$0.53	-4.81%
2019-09-30	2019-11-04	$30.05 million	-$0.54	-$0.52	-3.89%
2019-06-30	2019-08-05	$4.02 million	-$0.55	-$0.43	-28.69%
2019-03-31	2019-05-08	$4.02 million	-$0.46	-$0.47	2.09%
2018-12-31	2019-03-26	$3.44 million	-$0.52	-$0.60	13.51%
2018-09-30	2018-11-14	$3.38 million	-$0.57	-$0.28	-103.57%

Arvinas, Inc (ARVN) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Arvinas, Inc (ARVN) Chart:

Arvinas, Inc (ARVN) News:

Below you will find a list of latest news for Arvinas, Inc (ARVN) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Arvinas, Inc (ARVN) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2025-06-20	2.5	6.5	CALL	0	2	263.49	TRUE	0	0
2025-06-20	5	2.12	CALL	27	16619	101.9	TRUE	-0.43	-0.17
2025-06-20	7.5	0.6	CALL	1244	9184	107.14	FALSE	-0.15	-0.2
2025-06-20	10	0.15	CALL	205	1379	121.57	FALSE	-0.01	-0.06
2025-06-20	12.5	0.06	CALL	7	440	140.18	FALSE	0.06	0
2025-06-20	15	0	CALL	0	363	192.12	FALSE	0	0
2025-06-20	2.5	0.03	PUT	0	12	237.71	FALSE	0	0
2025-06-20	5	0.07	PUT	0	931	119.92	FALSE	0	0
2025-06-20	7.5	0.9	PUT	35	871	109.56	TRUE	0.1	0.13
2025-06-20	10	0	PUT	0	108	119.75	TRUE	0	0
2025-06-20	12.5	0	PUT	0	0	191.32	TRUE	0	0
2025-06-20	15	0	PUT	0	0	297.78	TRUE	0	0
2025-07-18	2.5	0	CALL	0	3	321.25	TRUE	0	0
2025-07-18	5	2.7	CALL	0	561	99.96	TRUE	0	0
2025-07-18	7.5	0.85	CALL	152	5848	92.24	FALSE	-0.13	-0.13
2025-07-18	10	0.4	CALL	0	10122	95.52	FALSE	0	0
2025-07-18	12.5	0.14	CALL	0	1141	123.54	FALSE	0	0
2025-07-18	15	0.1	CALL	0	314	175.41	FALSE	0	0
2025-07-18	17.5	0.07	CALL	0	226	164.74	FALSE	0	0
2025-07-18	20	0	CALL	0	338	214.92	FALSE	0	0
2025-07-18	22.5	0	CALL	0	13	226.3	FALSE	0	0
2025-07-18	25	0	CALL	0	126	239.38	FALSE	0	0
2025-07-18	30	0	CALL	0	374	228.35	FALSE	0	0
2025-07-18	35	0	CALL	0	131	279.01	FALSE	0	0
2025-07-18	40	0	CALL	0	61	270.48	FALSE	0	0
2025-07-18	2.5	0	PUT	0	200	153.86	FALSE	0	0
2025-07-18	5	0.1	PUT	0	1655	95.5	FALSE	0	0
2025-07-18	7.5	0.95	PUT	0	776	91.16	TRUE	0	0
2025-07-18	10	2.9	PUT	0	1325	76.23	TRUE	0	0
2025-07-18	12.5	0	PUT	0	534	177.95	TRUE	0	0
2025-07-18	15	0	PUT	0	43	0	TRUE	0	0
2025-07-18	17.5	0	PUT	0	2	142.12	TRUE	0	0
2025-07-18	20	0	PUT	0	0	268.86	TRUE	0	0
2025-07-18	22.5	0	PUT	0	0	199.92	TRUE	0	0
2025-07-18	25	0	PUT	0	0	276.68	TRUE	0	0
2025-07-18	30	0	PUT	0	0	287.82	TRUE	0	0
2025-07-18	35	0	PUT	0	0	346.83	TRUE	0	0
2025-07-18	40	0	PUT	0	0	358.34	TRUE	0	0
2025-10-17	2.5	4.7	CALL	2	13	136.23	TRUE	-0.3	-0.06
2025-10-17	5	2.63	CALL	0	34	89.54	TRUE	0	0
2025-10-17	7.5	1.34	CALL	8	5398	80.33	FALSE	-0.11	-0.08
2025-10-17	10	0.68	CALL	0	2729	70.41	FALSE	0	0
2025-10-17	12.5	0.25	CALL	1	2847	73.91	FALSE	-0.05	-0.17
2025-10-17	15	0.1	CALL	0	1978	78.54	FALSE	0	0
2025-10-17	17.5	0.08	CALL	0	126	114.92	FALSE	0	0
2025-10-17	20	0	CALL	0	21	125.46	FALSE	0	0
2025-10-17	22.5	0	CALL	0	1	134.4	FALSE	0	0
2025-10-17	25	0	CALL	0	2	139.89	FALSE	0	0
2025-10-17	30	0	CALL	0	0	152.76	FALSE	0	0
2025-10-17	35	0	CALL	0	0	163.23	FALSE	0	0
2025-10-17	40	0	CALL	0	2	197.88	FALSE	0	0
2025-10-17	2.5	0	PUT	0	28	179.51	FALSE	0	0
2025-10-17	5	0.4	PUT	16	125	83.11	FALSE	0.4	0
2025-10-17	7.5	1.47	PUT	0	385	78.65	TRUE	0	0
2025-10-17	10	3.7	PUT	0	544	75.31	TRUE	0	0
2025-10-17	12.5	6.25	PUT	0	23	76.31	TRUE	0	0
2025-10-17	15	0	PUT	0	776	80.85	TRUE	0	0
2025-10-17	17.5	0	PUT	0	0	146.67	TRUE	0	0
2025-10-17	20	0	PUT	0	0	184.65	TRUE	0	0
2025-10-17	22.5	0	PUT	0	0	143.52	TRUE	0	0
2025-10-17	25	0	PUT	0	0	148.12	TRUE	0	0
2025-10-17	30	0	PUT	0	0	209.46	TRUE	0	0
2025-10-17	35	0	PUT	0	0	181.73	TRUE	0	0
2025-10-17	40	0	PUT	0	0	170.55	TRUE	0	0
2025-12-19	2.5	0	CALL	0	7	128.66	TRUE	0	0
2025-12-19	5	3	CALL	0	317	79.91	TRUE	0	0
2025-12-19	7.5	1.46	CALL	1	1294	71.37	FALSE	-0.29	-0.17
2025-12-19	10	0.8	CALL	5	5438	72.87	FALSE	-0.07	-0.08
2025-12-19	12.5	0.36	CALL	11	1446	68.22	FALSE	0.36	0
2025-12-19	15	0.22	CALL	215	5159	71.05	FALSE	-0.02	-0.08
2025-12-19	17.5	0.35	CALL	0	518	83.57	FALSE	0	0
2025-12-19	20	0.1	CALL	0	421	87.29	FALSE	0	0
2025-12-19	22.5	0	CALL	0	62	111.02	FALSE	0	0
2025-12-19	25	0.2	CALL	0	104	117.47	FALSE	0	0
2025-12-19	30	0	CALL	0	134	128.23	FALSE	0	0
2025-12-19	35	0.1	CALL	0	260	108.97	FALSE	0	0
2025-12-19	2.5	0	PUT	0	27	125.77	FALSE	0	0
2025-12-19	5	0	PUT	0	1024	75.43	FALSE	0	0
2025-12-19	7.5	2.1	PUT	0	750	79.77	TRUE	0	0
2025-12-19	10	3.8	PUT	0	554	72.2	TRUE	0	0
2025-12-19	12.5	6.2	PUT	0	11	73.4	TRUE	0	0
2025-12-19	15	8.75	PUT	0	9	127.73	TRUE	0	0
2025-12-19	17.5	0	PUT	0	0	82.37	TRUE	0	0
2025-12-19	20	0	PUT	0	7	111.19	TRUE	0	0
2025-12-19	22.5	0	PUT	0	0	164.28	TRUE	0	0
2025-12-19	25	0	PUT	0	0	138.81	TRUE	0	0
2025-12-19	30	0	PUT	0	0	168.17	TRUE	0	0
2025-12-19	35	0	PUT	0	0	144.76	TRUE	0	0
2026-01-16	2.5	5.3	CALL	0	4	74.9	TRUE	0	0
2026-01-16	5	2.9	CALL	2	1	77.61	TRUE	2.9	0
2026-01-16	7.5	1.75	CALL	0	214	75.07	FALSE	0	0
2026-01-16	10	0.95	CALL	100	415	71.4	FALSE	0	0
2026-01-16	12.5	0.35	CALL	0	82	68.86	FALSE	0	0
2026-01-16	2.5	0	PUT	0	0	140.69	FALSE	0	0
2026-01-16	5	0	PUT	0	0	71.03	FALSE	0	0
2026-01-16	7.5	1.7	PUT	0	16	74.18	TRUE	0	0
2026-01-16	10	0	PUT	0	0	75.41	TRUE	0	0
2026-01-16	12.5	0	PUT	0	0	93.62	TRUE	0	0

Latest ARVN Trades:

Date	Shares	Price
Jun 13, 2022 7:59 PM EST	16	$36.97
Jun 13, 2022 7:59 PM EST	106	$36.93
Jun 13, 2022 7:59 PM EST	2	$36.98
Jun 13, 2022 7:59 PM EST	21	$36.92
Jun 13, 2022 7:59 PM EST	36	$36.92

Arvinas, Inc (ARVN) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-07-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120039888/0001209191-20-039888-index.htm
2019-10-07	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1655759/000000000019014356/0000000000-19-014356-index.htm
2019-10-07	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1655759/000000000019014357/0000000000-19-014357-index.htm
2020-10-13	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000031506620001801/0000315066-20-001801-index.htm
2018-10-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026069/0000899243-18-026069-index.htm
2018-10-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026071/0000899243-18-026071-index.htm
2018-10-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026072/0000899243-18-026072-index.htm
2018-10-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026073/0000899243-18-026073-index.htm
2018-10-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026075/0000899243-18-026075-index.htm
2018-10-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026076/0000899243-18-026076-index.htm
2018-10-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026078/0000899243-18-026078-index.htm
2018-10-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026089/0000899243-18-026089-index.htm
2019-01-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319001732/0000899243-19-001732-index.htm
2019-03-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319006227/0000899243-19-006227-index.htm
2019-03-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319006233/0000899243-19-006233-index.htm
2019-03-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319006234/0000899243-19-006234-index.htm
2019-03-05	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319006237/0000899243-19-006237-index.htm
2019-04-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319009401/0000899243-19-009401-index.htm
2019-04-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319009575/0000899243-19-009575-index.htm
2019-05-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319014874/0000899243-19-014874-index.htm
2019-05-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319014876/0000899243-19-014876-index.htm
2019-05-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319014878/0000899243-19-014878-index.htm
2019-05-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319014879/0000899243-19-014879-index.htm
2019-05-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319014881/0000899243-19-014881-index.htm
2019-05-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319014885/0000899243-19-014885-index.htm
2019-05-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319014888/0000899243-19-014888-index.htm
2019-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319016634/0000899243-19-016634-index.htm
2019-07-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319019621/0000899243-19-019621-index.htm
2019-07-26	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319020448/0000899243-19-020448-index.htm
2019-07-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319020450/0000899243-19-020450-index.htm
2019-07-31	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319020679/0000899243-19-020679-index.htm
2019-07-31	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319020681/0000899243-19-020681-index.htm
2019-07-31	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319020690/0000899243-19-020690-index.htm
2019-11-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924319027280/0000899243-19-027280-index.htm
2020-07-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924320019796/0000899243-20-019796-index.htm
2020-10-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000089924320028308/0000899243-20-028308-index.htm
2018-10-10	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000094787118000811/0000947871-18-000811-index.htm
2018-10-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000110465918060328/0001104659-18-060328-index.htm
2019-02-13	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000110465919007931/0001104659-19-007931-index.htm
2019-04-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000110465919019024/0001104659-19-019024-index.htm
2019-06-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000110465919034661/0001104659-19-034661-index.htm
2019-07-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000110465919038785/0001104659-19-038785-index.htm
2019-09-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000110465919050625/0001104659-19-050625-index.htm
2019-09-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000110465919050626/0001104659-19-050626-index.htm
2019-09-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000110465919051601/0001104659-19-051601-index.htm
2020-02-06	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000110465920011472/0001104659-20-011472-index.htm
2020-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000110465920020291/0001104659-20-020291-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000110465920021900/0001104659-20-021900-index.htm
2018-10-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000114420418052316/0001144204-18-052316-index.htm
2019-02-13	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000114420419007248/0001144204-19-007248-index.htm
2019-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000114420419008309/0001144204-19-008309-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000117266120000919/0001172661-20-000919-index.htm
2018-10-10	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000119312518296880/0001193125-18-296880-index.htm
2019-01-24	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000119312519015652/0001193125-19-015652-index.htm
2019-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000119312519039707/0001193125-19-039707-index.htm
2019-03-15	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312519076853/0001193125-19-076853-index.htm
2019-04-01	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312519094647/0001193125-19-094647-index.htm
2019-04-12	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1655759/000119312519105281/0001193125-19-105281-index.htm
2019-04-12	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1655759/000119312519105286/0001193125-19-105286-index.htm
2019-05-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312519141625/0001193125-19-141625-index.htm
2019-05-10	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1655759/000119312519144337/0001193125-19-144337-index.htm
2019-05-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312519158416/0001193125-19-158416-index.htm
2019-06-04	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312519164618/0001193125-19-164618-index.htm
2019-07-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312519194831/0001193125-19-194831-index.htm
2019-07-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312519202599/0001193125-19-202599-index.htm
2019-08-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312519212963/0001193125-19-212963-index.htm
2019-10-01	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1655759/000119312519259952/0001193125-19-259952-index.htm
2019-10-01	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1655759/000119312519259965/0001193125-19-259965-index.htm
2019-10-08	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1655759/000119312519264281/0001193125-19-264281-index.htm
2019-10-08	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1655759/000119312519264284/0001193125-19-264284-index.htm
2019-10-11	424B3	Prospectus [Rule 424(b)(3)]	https://www.sec.gov/Archives/edgar/data/1655759/000119312519266263/0001193125-19-266263-index.htm
2019-10-18	424B3	Prospectus [Rule 424(b)(3)]	https://www.sec.gov/Archives/edgar/data/1655759/000119312519270133/0001193125-19-270133-index.htm
2019-10-23	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312519272040/0001193125-19-272040-index.htm
2019-11-04	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312519283519/0001193125-19-283519-index.htm
2019-11-06	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1655759/000119312519286089/0001193125-19-286089-index.htm
2019-11-07	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1655759/000119312519287274/0001193125-19-287274-index.htm
2019-11-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312519289908/0001193125-19-289908-index.htm
2019-11-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312519297586/0001193125-19-297586-index.htm
2020-02-06	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000119312520026242/0001193125-20-026242-index.htm
2020-02-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312520026873/0001193125-20-026873-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1655759/000119312520038541/0001193125-20-038541-index.htm
2020-03-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312520073986/0001193125-20-073986-index.htm
2020-03-16	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1655759/000119312520074994/0001193125-20-074994-index.htm
2020-04-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312520123266/0001193125-20-123266-index.htm
2020-05-14	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312520141786/0001193125-20-141786-index.htm
2020-05-20	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1655759/000119312520147449/0001193125-20-147449-index.htm
2020-05-29	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312520154927/0001193125-20-154927-index.htm
2020-06-04	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312520160809/0001193125-20-160809-index.htm
2020-06-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312520162331/0001193125-20-162331-index.htm
2020-06-11	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312520166729/0001193125-20-166729-index.htm
2020-06-30	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312520184135/0001193125-20-184135-index.htm
2020-08-04	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312520209370/0001193125-20-209370-index.htm
2020-10-14	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312520268956/0001193125-20-268956-index.htm
2020-11-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1655759/000119312520286232/0001193125-20-286232-index.htm
2019-08-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919119045324/0001209191-19-045324-index.htm
2019-10-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919119051780/0001209191-19-051780-index.htm
2019-11-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919119055696/0001209191-19-055696-index.htm
2019-11-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919119056788/0001209191-19-056788-index.htm
2019-11-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919119057640/0001209191-19-057640-index.htm
2019-11-22	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919119057797/0001209191-19-057797-index.htm
2019-11-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919119057808/0001209191-19-057808-index.htm
2019-12-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919119061326/0001209191-19-061326-index.htm
2020-01-30	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120005638/0001209191-20-005638-index.htm
2020-02-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120008425/0001209191-20-008425-index.htm
2020-03-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120014636/0001209191-20-014636-index.htm
2020-03-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120014640/0001209191-20-014640-index.htm
2020-03-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120014678/0001209191-20-014678-index.htm
2020-03-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120014684/0001209191-20-014684-index.htm
2020-03-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020503/0001209191-20-020503-index.htm
2020-03-23	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020729/0001209191-20-020729-index.htm
2020-03-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020734/0001209191-20-020734-index.htm
2020-03-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020795/0001209191-20-020795-index.htm
2020-03-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020799/0001209191-20-020799-index.htm
2020-03-23	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020801/0001209191-20-020801-index.htm
2020-03-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020803/0001209191-20-020803-index.htm
2020-03-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120021041/0001209191-20-021041-index.htm
2020-03-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120021125/0001209191-20-021125-index.htm
2020-05-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120029413/0001209191-20-029413-index.htm
2020-05-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120029414/0001209191-20-029414-index.htm
2020-05-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120032172/0001209191-20-032172-index.htm
2020-05-27	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120032410/0001209191-20-032410-index.htm
2020-06-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120034583/0001209191-20-034583-index.htm
2020-06-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120034584/0001209191-20-034584-index.htm
2020-06-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120034585/0001209191-20-034585-index.htm
2020-06-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120034586/0001209191-20-034586-index.htm
2020-06-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120034587/0001209191-20-034587-index.htm
2020-06-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120034588/0001209191-20-034588-index.htm
2020-06-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120034589/0001209191-20-034589-index.htm
2020-06-04	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120034590/0001209191-20-034590-index.htm
2020-06-12	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120036357/0001209191-20-036357-index.htm
2020-06-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120036363/0001209191-20-036363-index.htm
2020-06-19	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120037980/0001209191-20-037980-index.htm
2020-07-01	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120039884/0001209191-20-039884-index.htm
2020-07-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120039888/0001209191-20-039888-index.htm
2020-08-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000120919120047315/0001209191-20-047315-index.htm
2018-10-09	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1655759/000140508618000206/0001405086-18-000206-index.htm
2018-11-14	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1655759/000156459018029393/0001564590-18-029393-index.htm
2019-03-26	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1655759/000156459019009357/0001564590-19-009357-index.htm
2019-05-09	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1655759/000156459019017454/0001564590-19-017454-index.htm
2019-08-05	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1655759/000156459019028501/0001564590-19-028501-index.htm
2019-11-04	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1655759/000156459019039841/0001564590-19-039841-index.htm
2020-03-16	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1655759/000156459020011004/0001564590-20-011004-index.htm
2020-04-21	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1655759/000156459020017721/0001564590-20-017721-index.htm
2020-04-21	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1655759/000156459020017724/0001564590-20-017724-index.htm
2020-04-28	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1655759/000156459020019266/0001564590-20-019266-index.htm
2020-08-04	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1655759/000156459020036168/0001564590-20-036168-index.htm
2020-11-05	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1655759/000156459020051413/0001564590-20-051413-index.htm
2019-07-19	D	Notice of Exempt Offering of Securities	https://www.sec.gov/Archives/edgar/data/1655759/000165575919000001/0001655759-19-000001-index.htm
2019-10-10	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1655759/999999999519002291/9999999995-19-002291-index.htm
2019-10-10	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1655759/999999999519002292/9999999995-19-002292-index.htm
2019-05-03	CT ORDER	Confidential treatment order	https://www.sec.gov/Archives/edgar/data/1655759/999999999719003840/9999999997-19-003840-index.htm

Arvinas, Inc (ARVN) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Arvinas, Inc (ARVN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1204%
Institutional Ownership: 7678%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2019-06-27	5AM VENTURES III, L.P.	10% Share Holder	Sell	11,306.00	21.75	245,905.50	100,207.00	https://www.sec.gov/Archives/edgar/data/1655759/000110465919038785/0001104659-19-038785-index.htm
2019-06-07	5AM VENTURES III, L.P.	10% Share Holder	Sell	4,774.00	19.65	93,809.10	111,513.00	https://www.sec.gov/Archives/edgar/data/1655759/000110465919034661/0001104659-19-034661-index.htm
2019-03-28	5AM VENTURES III, L.P.	10% Share Holder	Sell	9,073.00	14.16	128,451.00	116,287.00	https://www.sec.gov/Archives/edgar/data/1655759/000110465919019024/0001104659-19-019024-index.htm
2020-02-07	Sean A Cassidy	Chief Financial Officer	Sell	30.00	54.10	1,623.00	149,115.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120008425/0001209191-20-008425-index.htm
2020-02-07	Sean A Cassidy	Chief Financial Officer	Sell	1,302.00	52.86	68,823.72	149,145.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120008425/0001209191-20-008425-index.htm
2020-05-12	Sean A Cassidy	Chief Financial Officer	Sell	10,000.00	60.00	600,000.00	150,422.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120029413/0001209191-20-029413-index.htm
2020-02-07	Sean A Cassidy	Chief Financial Officer	Sell	1,880.00	52.30	98,324.00	150,447.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120008425/0001209191-20-008425-index.htm
2020-05-13	Sean A Cassidy	Chief Financial Officer	Buy	1,356.00	16.00	21,696.00	151,778.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120029414/0001209191-20-029414-index.htm
2020-02-07	Sean A Cassidy	Chief Financial Officer	Sell	2,190.00	50.97	111,624.30	152,327.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120008425/0001209191-20-008425-index.htm
2020-03-19	Sean A Cassidy	Chief Financial Officer	Sell	1,514.00	37.61	56,941.54	152,392.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020795/0001209191-20-020795-index.htm
2020-03-19	Sean A Cassidy	Chief Financial Officer	Buy	4,791.00			153,906.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020795/0001209191-20-020795-index.htm
2020-02-07	Sean A Cassidy	Chief Financial Officer	Sell	4,598.00	49.97	229,762.06	154,517.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120008425/0001209191-20-008425-index.htm
2019-11-19	Sean A Cassidy	Chief Financial Officer	Sell	10,000.00	32.00	320,000.00	159,115.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919119057640/0001209191-19-057640-index.htm
2019-07-29	Sean A Cassidy	Chief Financial Officer	Sell	60.00	28.03	1,681.80	162,865.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924319020690/0000899243-19-020690-index.htm
2019-07-29	Sean A Cassidy	Chief Financial Officer	Sell	1,108.00	27.04	29,960.32	162,925.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924319020690/0000899243-19-020690-index.htm
2019-07-29	Sean A Cassidy	Chief Financial Officer	Sell	10,777.00	26.13	281,603.01	164,033.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924319020690/0000899243-19-020690-index.htm
2019-08-07	Sean A Cassidy	Chief Financial Officer	Buy	6,250.00	16.00	100,000.00	169,115.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919119045324/0001209191-19-045324-index.htm
2018-10-01	Sean A Cassidy	Chief Financial Officer	Buy	1,600.00	16.00	25,600.00	169,465.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026071/0000899243-18-026071-index.htm
2018-10-01	Liam Ratcliffe	Director	Buy	625,000.00	16.00	10,000,000.00	1,908,048.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026073/0000899243-18-026073-index.htm
2020-08-14	Ronald Peck	Chief Medical Officer	Sell	1,256.00	27.46	34,489.76	2,754.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120047315/0001209191-20-047315-index.htm
2020-03-24	Briggs Morrison	Director	Buy	2,500.00	38.18	95,450.00	29,520.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120021125/0001209191-20-021125-index.htm
2018-10-01	Jakob Loven	Director	Buy	312,500.00	16.00	5,000,000.00	312,500.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026069/0000899243-18-026069-index.htm
2018-10-01	RA CAPITAL MANAGEMENT, LLC	Insider	Buy	1,000,000.00	16.00	16,000,000.00	3,138,412.00	https://www.sec.gov/Archives/edgar/data/1655759/000114420418052316/0001144204-18-052316-index.htm
2018-10-01	Edward Moore Jr. Kennedy	Director	Buy	21,000.00	16.00	336,000.00	34,385.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026076/0000899243-18-026076-index.htm
2019-06-28	5AM VENTURES III, L.P.	10% Share Holder	Sell	350,955.00	22.02	7,728,029.10	3,537,261.00	https://www.sec.gov/Archives/edgar/data/1655759/000110465919038785/0001104659-19-038785-index.htm
2018-10-01	Liam Ratcliffe	Director	Buy	375,000.00	16.00	6,000,000.00	375,000.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026073/0000899243-18-026073-index.htm
2019-06-27	5AM VENTURES III, L.P.	10% Share Holder	Sell	438,694.00	21.75	9,541,594.50	3,888,216.00	https://www.sec.gov/Archives/edgar/data/1655759/000110465919038785/0001104659-19-038785-index.htm
2020-08-14	Ronald Peck	Chief Medical Officer	Buy	4,010.00			4,010.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120047315/0001209191-20-047315-index.htm
2019-06-07	5AM VENTURES III, L.P.	10% Share Holder	Sell	185,226.00	19.65	3,639,690.90	4,326,910.00	https://www.sec.gov/Archives/edgar/data/1655759/000110465919034661/0001104659-19-034661-index.htm
2019-03-28	5AM VENTURES III, L.P.	10% Share Holder	Sell	352,056.00	14.16	4,984,232.82	4,512,136.00	https://www.sec.gov/Archives/edgar/data/1655759/000110465919019024/0001104659-19-019024-index.htm
2018-10-01	TIMOTHY M SHANNON	Director	Buy	4,000.00	16.00	64,000.00	55,398.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026078/0000899243-18-026078-index.htm
2019-11-13	Ian Taylor	Chief Scientific Officer	Sell	10,000.00	28.00	280,000.00	55,496.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919119056788/0001209191-19-056788-index.htm
2019-03-28	TIMOTHY M SHANNON	Director	Buy	3,500.00	14.69	51,409.75	58,898.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924319009401/0000899243-19-009401-index.htm
2020-03-18	Bradley Albert Margus	Director	Sell	40,000.00	37.46	1,498,400.00	59,463.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020503/0001209191-20-020503-index.htm
2020-03-20	TIMOTHY M SHANNON	Director	Buy	2,500.00	40.00	100,000.00	61,623.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020734/0001209191-20-020734-index.htm
2020-05-26	Liam Ratcliffe	Director	Buy	6,500.00	22.06	143,390.00	6,500.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120032410/0001209191-20-032410-index.htm
2019-11-05	Ian Taylor	Chief Scientific Officer	Sell	1,000.00	24.05	24,050.00	65,496.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919119055696/0001209191-19-055696-index.htm
2019-11-05	Ian Taylor	Chief Scientific Officer	Sell	9,000.00	23.55	211,950.00	66,496.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919119055696/0001209191-19-055696-index.htm
2019-11-12	Liam Ratcliffe	Director	Buy	680,000.00	22.00	14,960,000.00	680,000.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924319027280/0000899243-19-027280-index.htm
2020-01-28	Ian Taylor	Chief Scientific Officer	Buy	13,042.00	16.00	208,672.00	68,538.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120005638/0001209191-20-005638-index.htm
2020-03-19	Ian Taylor	Chief Scientific Officer	Sell	826.00	37.61	31,065.86	70,398.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020799/0001209191-20-020799-index.htm
2020-03-19	Ian Taylor	Chief Scientific Officer	Buy	2,686.00			71,224.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020799/0001209191-20-020799-index.htm
2020-05-26	TIMOTHY M SHANNON	Director	Buy	12,923.00	22.06	285,081.38	74,546.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120032172/0001209191-20-032172-index.htm
2019-09-30	Ian Taylor	Chief Scientific Officer	Sell	1,300.00	22.54	29,302.00	75,496.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919119051780/0001209191-19-051780-index.htm
2019-09-30	Ian Taylor	Chief Scientific Officer	Sell	8,700.00	21.76	189,312.00	76,796.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919119051780/0001209191-19-051780-index.htm
2018-10-01	John G Houston	President and CEO	Buy	30,000.00	16.00	480,000.00	772,860.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026075/0000899243-18-026075-index.htm
2020-06-02	TIMOTHY M SHANNON	Director	Buy	3,000.00	32.30	96,900.00	77,546.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120034590/0001209191-20-034590-index.htm
2020-06-17	TIMOTHY M SHANNON	Director	Buy	2,000.00	30.26	60,519.80	79,546.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120037980/0001209191-20-037980-index.htm
2019-12-17	John G Houston	President and CEO	Buy	12,500.00	16.00	200,000.00	797,844.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919119061326/0001209191-19-061326-index.htm
2020-03-19	John G Houston	President and CEO	Sell	5,405.00	37.61	203,282.05	809,950.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020801/0001209191-20-020801-index.htm
2020-03-19	John G Houston	President and CEO	Buy	17,511.00			815,355.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120020801/0001209191-20-020801-index.htm
2020-03-23	John G Houston	President and CEO	Buy	6,250.00	16.00	100,000.00	816,200.00	https://www.sec.gov/Archives/edgar/data/1655759/000120919120021041/0001209191-20-021041-index.htm
2019-03-29	Ian Taylor	Chief Scientific Officer	Buy	1,000.00	14.66	14,660.30	85,496.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924319009575/0000899243-19-009575-index.htm
2019-06-28	5AM VENTURES III, L.P.	10% Share Holder	Sell	9,045.00	22.02	199,170.90	91,162.00	https://www.sec.gov/Archives/edgar/data/1655759/000110465919038785/0001104659-19-038785-index.htm
2018-10-01	Bradley Albert Margus	Director	Buy	40,000.00	16.00	640,000.00	99,463.00	https://www.sec.gov/Archives/edgar/data/1655759/000089924318026072/0000899243-18-026072-index.htm

Arvinas, Inc

(NASDAQ:ARVN)